Global Systemic Mastocytosis Treatment Market Insights and Forecast to 2027

SKU ID : QYR-18075138 | Publishing Date : 21-Apr-2021 | No. of pages : 116

Detailed TOC of Global Systemic Mastocytosis Treatment Market Insights and Forecast to 2027

1 Study Coverage
    1.1 Systemic Mastocytosis Treatment Product Introduction
    1.2 Market by Type
        1.2.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Type
        1.4.2 AK-002
        1.4.3 BLU-285
        1.2.4 Brentuximab Vedotin
        1.2.5 Crenolanib Besylate
        1.2.6 Cromolyn Sodium
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Systemic Mastocytosis Treatment Market Size Growth Rate by Application
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Homecare
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Systemic Mastocytosis Treatment Sales Estimates and Forecasts 2016-2027
    2.2 Global Systemic Mastocytosis Treatment Revenue Estimates and Forecasts 2016-2027
    2.3 Global Systemic Mastocytosis Treatment Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Systemic Mastocytosis Treatment Regions by Sales
        2.4.1 Global Top Systemic Mastocytosis Treatment Regions by Sales (2016-2021)
        2.4.2 Global Top Systemic Mastocytosis Treatment Regions by Sales (2022-2027)
    2.5 Global Top Systemic Mastocytosis Treatment Regions by Revenue
        2.5.1 Global Top Systemic Mastocytosis Treatment Regions by Revenue (2016-2021)
        2.5.2 Global Top Systemic Mastocytosis Treatment Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Systemic Mastocytosis Treatment Sales by Manufacturers
        3.1.1 Global Top Systemic Mastocytosis Treatment Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Systemic Mastocytosis Treatment Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Systemic Mastocytosis Treatment Sales in 2020
    3.2 Global Systemic Mastocytosis Treatment Revenue by Manufacturers
        3.2.1 Global Top Systemic Mastocytosis Treatment Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Systemic Mastocytosis Treatment Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Systemic Mastocytosis Treatment Revenue in 2020
    3.3 Global Systemic Mastocytosis Treatment Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Systemic Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Systemic Mastocytosis Treatment Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Systemic Mastocytosis Treatment Sales by Type
        4.1.1 Global Systemic Mastocytosis Treatment Historical Sales by Type (2016-2021)
        4.1.2 Global Systemic Mastocytosis Treatment Forecasted Sales by Type (2022-2027)
        4.1.3 Global Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    4.2 Global Systemic Mastocytosis Treatment Revenue by Type
        4.2.1 Global Systemic Mastocytosis Treatment Historical Revenue by Type (2016-2021)
        4.2.2 Global Systemic Mastocytosis Treatment Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    4.3 Global Systemic Mastocytosis Treatment Price by Type
        4.3.1 Global Systemic Mastocytosis Treatment Price by Type (2016-2021)
        4.3.2 Global Systemic Mastocytosis Treatment Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Systemic Mastocytosis Treatment Sales by Application
        5.1.1 Global Systemic Mastocytosis Treatment Historical Sales by Application (2016-2021)
        5.1.2 Global Systemic Mastocytosis Treatment Forecasted Sales by Application (2022-2027)
        5.1.3 Global Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    5.2 Global Systemic Mastocytosis Treatment Revenue by Application
        5.2.1 Global Systemic Mastocytosis Treatment Historical Revenue by Application (2016-2021)
        5.2.2 Global Systemic Mastocytosis Treatment Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    5.3 Global Systemic Mastocytosis Treatment Price by Application
        5.3.1 Global Systemic Mastocytosis Treatment Price by Application (2016-2021)
        5.3.2 Global Systemic Mastocytosis Treatment Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Systemic Mastocytosis Treatment Market Size by Type
        6.1.1 North America Systemic Mastocytosis Treatment Sales by Type (2016-2027)
        6.1.2 North America Systemic Mastocytosis Treatment Revenue by Type (2016-2027)
    6.2 North America Systemic Mastocytosis Treatment Market Size by Application
        6.2.1 North America Systemic Mastocytosis Treatment Sales by Application (2016-2027)
        6.2.2 North America Systemic Mastocytosis Treatment Revenue by Application (2016-2027)
    6.3 North America Systemic Mastocytosis Treatment Market Size by Country
        6.3.1 North America Systemic Mastocytosis Treatment Sales by Country (2016-2027)
        6.3.2 North America Systemic Mastocytosis Treatment Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Systemic Mastocytosis Treatment Market Size by Type
        7.1.1 Europe Systemic Mastocytosis Treatment Sales by Type (2017-2027)
        7.1.2 Europe Systemic Mastocytosis Treatment Revenue by Type (2017-2027)
    7.2 Europe Systemic Mastocytosis Treatment Market Size by Application
        7.2.1 Europe Systemic Mastocytosis Treatment Sales by Application (2017-2027)
        7.2.2 Europe Systemic Mastocytosis Treatment Revenue by Application (2017-2027)
    7.3 Europe Systemic Mastocytosis Treatment Market Size by Country
        7.3.1 Europe Systemic Mastocytosis Treatment Sales by Country (2017-2027)
        7.3.2 Europe Systemic Mastocytosis Treatment Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Systemic Mastocytosis Treatment Market Size by Type
        8.1.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Type (2018-2027)
        8.1.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Type (2018-2027)
    8.2 Asia Pacific Systemic Mastocytosis Treatment Market Size by Application
        8.2.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Application (2018-2027)
        8.2.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Application (2018-2027)
    8.3 Asia Pacific Systemic Mastocytosis Treatment Market Size by Region
        8.3.1 Asia Pacific Systemic Mastocytosis Treatment Sales by Region (2018-2027)
        8.3.2 Asia Pacific Systemic Mastocytosis Treatment Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Systemic Mastocytosis Treatment Market Size by Type
        9.1.1 Latin America Systemic Mastocytosis Treatment Sales by Type (2019-2027)
        9.1.2 Latin America Systemic Mastocytosis Treatment Revenue by Type (2019-2027)
    9.2 Latin America Systemic Mastocytosis Treatment Market Size by Application
        9.2.1 Latin America Systemic Mastocytosis Treatment Sales by Application (2019-2027)
        9.2.2 Latin America Systemic Mastocytosis Treatment Revenue by Application (2019-2027)
    9.3 Latin America Systemic Mastocytosis Treatment Market Size by Country
        9.3.1 Latin America Systemic Mastocytosis Treatment Sales by Country (2019-2027)
        9.3.2 Latin America Systemic Mastocytosis Treatment Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Type
        6.1.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Type (2016-2027)
    6.2 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Application
        6.2.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Application (2016-2027)
    6.3 Middle East and Africa Systemic Mastocytosis Treatment Market Size by Country
        6.3.1 Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 AB Science SA
        11.1.1 AB Science SA Corporation Information
        11.1.2 AB Science SA Overview
        11.1.3 AB Science SA Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AB Science SA Systemic Mastocytosis Treatment Product Description
        11.1.5 AB Science SA Related Developments
    11.2 AbbVie Inc
        11.2.1 AbbVie Inc Corporation Information
        11.2.2 AbbVie Inc Overview
        11.2.3 AbbVie Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 AbbVie Inc Systemic Mastocytosis Treatment Product Description
        11.2.5 AbbVie Inc Related Developments
    11.3 Arog Pharmaceuticals Inc
        11.3.1 Arog Pharmaceuticals Inc Corporation Information
        11.3.2 Arog Pharmaceuticals Inc Overview
        11.3.3 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product Description
        11.3.5 Arog Pharmaceuticals Inc Related Developments
    11.4 Blueprint Medicines Corp
        11.4.1 Blueprint Medicines Corp Corporation Information
        11.4.2 Blueprint Medicines Corp Overview
        11.4.3 Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Blueprint Medicines Corp Systemic Mastocytosis Treatment Product Description
        11.4.5 Blueprint Medicines Corp Related Developments
    11.5 Bristol-Myers Squibb Company
        11.5.1 Bristol-Myers Squibb Company Corporation Information
        11.5.2 Bristol-Myers Squibb Company Overview
        11.5.3 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product Description
        11.5.5 Bristol-Myers Squibb Company Related Developments
    11.6 Deciphera Pharmaceuticals LLC
        11.6.1 Deciphera Pharmaceuticals LLC Corporation Information
        11.6.2 Deciphera Pharmaceuticals LLC Overview
        11.6.3 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product Description
        11.6.5 Deciphera Pharmaceuticals LLC Related Developments
    11.7 Novartis AG
        11.7.1 Novartis AG Corporation Information
        11.7.2 Novartis AG Overview
        11.7.3 Novartis AG Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Novartis AG Systemic Mastocytosis Treatment Product Description
        11.7.5 Novartis AG Related Developments
    11.8 Patara Pharma Inc
        11.8.1 Patara Pharma Inc Corporation Information
        11.8.2 Patara Pharma Inc Overview
        11.8.3 Patara Pharma Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Patara Pharma Inc Systemic Mastocytosis Treatment Product Description
        11.8.5 Patara Pharma Inc Related Developments
    11.9 Seattle Genetics Inc
        11.9.1 Seattle Genetics Inc Corporation Information
        11.9.2 Seattle Genetics Inc Overview
        11.9.3 Seattle Genetics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Seattle Genetics Inc Systemic Mastocytosis Treatment Product Description
        11.9.5 Seattle Genetics Inc Related Developments
    11.10 Stemline Therapeutics Inc
        11.10.1 Stemline Therapeutics Inc Corporation Information
        11.10.2 Stemline Therapeutics Inc Overview
        11.10.3 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.10.4 Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product Description
        11.10.5 Stemline Therapeutics Inc Related Developments
    11.1 AB Science SA
        11.1.1 AB Science SA Corporation Information
        11.1.2 AB Science SA Overview
        11.1.3 AB Science SA Systemic Mastocytosis Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 AB Science SA Systemic Mastocytosis Treatment Product Description
        11.1.5 AB Science SA Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Systemic Mastocytosis Treatment Value Chain Analysis
    12.2 Systemic Mastocytosis Treatment Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Systemic Mastocytosis Treatment Production Mode & Process
    12.4 Systemic Mastocytosis Treatment Sales and Marketing
        12.4.1 Systemic Mastocytosis Treatment Sales Channels
        12.4.2 Systemic Mastocytosis Treatment Distributors
    12.5 Systemic Mastocytosis Treatment Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Systemic Mastocytosis Treatment Industry Trends
    13.2 Systemic Mastocytosis Treatment Market Drivers
    13.3 Systemic Mastocytosis Treatment Market Challenges
    13.4 Systemic Mastocytosis Treatment Market Restraints

14 Key Findings in The Global Systemic Mastocytosis Treatment Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Figures, Tables and Charts Available in Global Systemic Mastocytosis Treatment Market Insights and Forecast to 2027

List of Tables
    Table 1. Global Systemic Mastocytosis Treatment Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of AK-002
    Table 3. Major Manufacturers of BLU-285
    Table 4. Major Manufacturers of Brentuximab Vedotin
    Table 5. Major Manufacturers of Crenolanib Besylate
    Table 6. Major Manufacturers of Cromolyn Sodium
    Table 7. Major Manufacturers of Others
    Table 8. Global Systemic Mastocytosis Treatment Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 9. Global Systemic Mastocytosis Treatment Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 10. Global Systemic Mastocytosis Treatment Sales by Region (2016-2021) & (K Pcs)
    Table 11. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2016-2021)
    Table 12. Global Systemic Mastocytosis Treatment Sales by Region (2016-2021) & (K Pcs)
    Table 13. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2022-2027)
    Table 14. Global Systemic Mastocytosis Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 15. Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2016-2021)
    Table 16. Global Systemic Mastocytosis Treatment Revenue by Region (2022-2027) & (US$ Million)
    Table 17. Global Systemic Mastocytosis Treatment Revenue Market Share by Region (2022-2027)
    Table 18. Global Systemic Mastocytosis Treatment Sales by Manufacturers (2016-2021) & (K Pcs)
    Table 19. Global Systemic Mastocytosis Treatment Sales Share by Manufacturers (2016-2021)
    Table 20. Global Systemic Mastocytosis Treatment Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 21. Global Systemic Mastocytosis Treatment Revenue Share by Manufacturers (2016-2021)
    Table 22. Systemic Mastocytosis Treatment Price by Manufacturers 2016-2021 (USD/Pcs)
    Table 23. Global Systemic Mastocytosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Systemic Mastocytosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Systemic Mastocytosis Treatment as of 2020)
    Table 25. Systemic Mastocytosis Treatment Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Systemic Mastocytosis Treatment Product Offered
    Table 27. Date of Manufacturers Enter into Systemic Mastocytosis Treatment Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 30. Global Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 31. Global Systemic Mastocytosis Treatment Sales Share by Type (2016-2021)
    Table 32. Global Systemic Mastocytosis Treatment Sales Share by Type (2022-2027)
    Table 33. Global Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 34. Global Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 35. Global Systemic Mastocytosis Treatment Revenue Share by Type (2016-2021)
    Table 36. Global Systemic Mastocytosis Treatment Revenue Share by Type (2022-2027)
    Table 37. Systemic Mastocytosis Treatment Price by Type (2016-2021) & (USD/Pcs)
    Table 38. Global Systemic Mastocytosis Treatment Price Forecast by Type (2022-2027) & (USD/Pcs)
    Table 39. Global Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 40. Global Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 41. Global Systemic Mastocytosis Treatment Sales Share by Application (2016-2021)
    Table 42. Global Systemic Mastocytosis Treatment Sales Share by Application (2022-2027)
    Table 43. Global Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 44. Global Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 45. Global Systemic Mastocytosis Treatment Revenue Share by Application (2016-2021)
    Table 46. Global Systemic Mastocytosis Treatment Revenue Share by Application (2022-2027)
    Table 47. Systemic Mastocytosis Treatment Price by Application (2016-2021) & (USD/Pcs)
    Table 48. Global Systemic Mastocytosis Treatment Price Forecast by Application (2022-2027) & (USD/Pcs)
    Table 49. North America Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 50. North America Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 51. North America Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 52. North America Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 53. North America Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 54. North America Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 55. North America Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 56. North America Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 57. North America Systemic Mastocytosis Treatment Sales by Country (2016-2021) & (K Pcs)
    Table 58. North America Systemic Mastocytosis Treatment Sales by Country (2022-2027) & (K Pcs)
    Table 59. North America Systemic Mastocytosis Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 60. North America Systemic Mastocytosis Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 61. Europe Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 62. Europe Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 63. Europe Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 64. Europe Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 65. Europe Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 66. Europe Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 67. Europe Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 68. Europe Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 69. Europe Systemic Mastocytosis Treatment Sales by Country (2016-2021) & (K Pcs)
    Table 70. Europe Systemic Mastocytosis Treatment Sales by Country (2022-2027) & (K Pcs)
    Table 71. Europe Systemic Mastocytosis Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 72. Europe Systemic Mastocytosis Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 73. Asia Pacific Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 74. Asia Pacific Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 75. Asia Pacific Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 77. Asia Pacific Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 78. Asia Pacific Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 79. Asia Pacific Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 80. Asia Pacific Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 81. Asia Pacific Systemic Mastocytosis Treatment Sales by Region (2016-2021) & (K Pcs)
    Table 82. Asia Pacific Systemic Mastocytosis Treatment Sales by Region (2022-2027) & (K Pcs)
    Table 83. Asia Pacific Systemic Mastocytosis Treatment Revenue by Region (2016-2021) & (US$ Million)
    Table 84. Asia Pacific Systemic Mastocytosis Treatment Revenue by Region (2022-2027) & (US$ Million)
    Table 85. Latin America Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 86. Latin America Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 87. Latin America Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 88. Latin America Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 89. Latin America Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 90. Latin America Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 91. Latin America Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 92. Latin America Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 93. Latin America Systemic Mastocytosis Treatment Sales by Country (2016-2021) & (K Pcs)
    Table 94. Latin America Systemic Mastocytosis Treatment Sales by Country (2022-2027) & (K Pcs)
    Table 95. Latin America Systemic Mastocytosis Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 96. Latin America Systemic Mastocytosis Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 97. Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2016-2021) & (K Pcs)
    Table 98. Middle East and Africa Systemic Mastocytosis Treatment Sales by Type (2022-2027) & (K Pcs)
    Table 99. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Type (2016-2021) & (US$ Million)
    Table 100. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Type (2022-2027) & (US$ Million)
    Table 101. Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2016-2021) & (K Pcs)
    Table 102. Middle East and Africa Systemic Mastocytosis Treatment Sales by Application (2022-2027) & (K Pcs)
    Table 103. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Application (2016-2021) & (US$ Million)
    Table 104. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Application (2022-2027) & (US$ Million)
    Table 105. Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2016-2021) & (K Pcs)
    Table 106. Middle East and Africa Systemic Mastocytosis Treatment Sales by Country (2022-2027) & (K Pcs)
    Table 107. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country (2016-2021) & (US$ Million)
    Table 108. Middle East and Africa Systemic Mastocytosis Treatment Revenue by Country (2022-2027) & (US$ Million)
    Table 109. AB Science SA Corporation Information
    Table 110. AB Science SA Description and Major Businesses
    Table 111. AB Science SA Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 112. AB Science SA Systemic Mastocytosis Treatment Product
    Table 113. AB Science SA Recent Developments
    Table 114. AbbVie Inc Corporation Information
    Table 115. AbbVie Inc Description and Major Businesses
    Table 116. AbbVie Inc Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 117. AbbVie Inc Systemic Mastocytosis Treatment Product
    Table 118. AbbVie Inc Recent Developments
    Table 119. Arog Pharmaceuticals Inc Corporation Information
    Table 120. Arog Pharmaceuticals Inc Description and Major Businesses
    Table 121. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 122. Arog Pharmaceuticals Inc Systemic Mastocytosis Treatment Product
    Table 123. Arog Pharmaceuticals Inc Recent Developments
    Table 124. Blueprint Medicines Corp Corporation Information
    Table 125. Blueprint Medicines Corp Description and Major Businesses
    Table 126. Blueprint Medicines Corp Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 127. Blueprint Medicines Corp Systemic Mastocytosis Treatment Product
    Table 128. Blueprint Medicines Corp Recent Developments
    Table 129. Bristol-Myers Squibb Company Corporation Information
    Table 130. Bristol-Myers Squibb Company Description and Major Businesses
    Table 131. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 132. Bristol-Myers Squibb Company Systemic Mastocytosis Treatment Product
    Table 133. Bristol-Myers Squibb Company Recent Developments
    Table 134. Deciphera Pharmaceuticals LLC Corporation Information
    Table 135. Deciphera Pharmaceuticals LLC Description and Major Businesses
    Table 136. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 137. Deciphera Pharmaceuticals LLC Systemic Mastocytosis Treatment Product
    Table 138. Deciphera Pharmaceuticals LLC Recent Developments
    Table 139. Novartis AG Corporation Information
    Table 140. Novartis AG Description and Major Businesses
    Table 141. Novartis AG Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 142. Novartis AG Systemic Mastocytosis Treatment Product
    Table 143. Novartis AG Recent Developments
    Table 144. Patara Pharma Inc Corporation Information
    Table 145. Patara Pharma Inc Description and Major Businesses
    Table 146. Patara Pharma Inc Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 147. Patara Pharma Inc Systemic Mastocytosis Treatment Product
    Table 148. Patara Pharma Inc Recent Developments
    Table 149. Seattle Genetics Inc Corporation Information
    Table 150. Seattle Genetics Inc Description and Major Businesses
    Table 151. Seattle Genetics Inc Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 152. Seattle Genetics Inc Systemic Mastocytosis Treatment Product
    Table 153. Seattle Genetics Inc Recent Developments
    Table 154. Stemline Therapeutics Inc Corporation Information
    Table 155. Stemline Therapeutics Inc Description and Major Businesses
    Table 156. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
    Table 157. Stemline Therapeutics Inc Systemic Mastocytosis Treatment Product
    Table 158. Stemline Therapeutics Inc Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Systemic Mastocytosis Treatment Distributors List
    Table 162. Systemic Mastocytosis Treatment Customers List
    Table 163. Systemic Mastocytosis Treatment Market Trends
    Table 164. Systemic Mastocytosis Treatment Market Drivers
    Table 165. Systemic Mastocytosis Treatment Market Challenges
    Table 166. Systemic Mastocytosis Treatment Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Systemic Mastocytosis Treatment Product Picture
    Figure 2. Global Systemic Mastocytosis Treatment Market Share by Type in 2020 & 2027
    Figure 3. AK-002 Product Picture
    Figure 4. BLU-285 Product Picture
    Figure 5. Brentuximab Vedotin Product Picture
    Figure 6. Crenolanib Besylate Product Picture
    Figure 7. Cromolyn Sodium Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Systemic Mastocytosis Treatment Sales Market Share by Application in 2020 & 2027
    Figure 10. Clinic
    Figure 11. Hospital
    Figure 12. Homecare
    Figure 13. Systemic Mastocytosis Treatment Report Years Considered
    Figure 14. Global Systemic Mastocytosis Treatment Sales 2016-2027 (K Pcs)
    Figure 15. Global Systemic Mastocytosis Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Systemic Mastocytosis Treatment Revenue 2016-2027 (US$ Million)
    Figure 17. Global Systemic Mastocytosis Treatment Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 18. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2016-2021)
    Figure 19. Global Systemic Mastocytosis Treatment Sales Market Share by Region (2022-2027)
    Figure 20. North America Systemic Mastocytosis Treatment Sales YoY (2016-2027) & (K Pcs)
    Figure 21. North America Systemic Mastocytosis Treatment Revenue YoY (2016-2027) & (US$ Million)
    Figure 22. Europe Systemic Mastocytosis Treatment Sales YoY (2016-2027) & (K Pcs)
    Figure 23. Europe Systemic Mastocytosis Treatment Revenue YoY (2016-2027) & (US$ Million)
    Figure 24. Asia-Pacific Systemic Mastocytosis Treatment Sales YoY (2016-2027) & (K Pcs)
    Figure 25. Asia-Pacific Systemic Mastocytosis Treatment Revenue YoY (2016-2027) & (US$ Million)
    Figure 26. Latin America Systemic Mastocytosis Treatment Sales YoY (2016-2027) & (K Pcs)
    Figure 27. Latin America Systemic Mastocytosis Treatment Revenue YoY (2016-2027) & (US$ Million)
    Figure 28. Middle East & Africa Systemic Mastocytosis Treatment Sales YoY (2016-2027) & (K Pcs)
    Figure 29. Middle East & Africa Systemic Mastocytosis Treatment Revenue YoY (2016-2027) & (US$ Million)
    Figure 30. The Top 10 and Top 5 Players Market Share by Systemic Mastocytosis Treatment Sales in 2020
    Figure 31. The Top 10 and Top 5 Players Market Share by Systemic Mastocytosis Treatment Revenue in 2020
    Figure 32. Systemic Mastocytosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 33. Global Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 34. Global Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 35. Global Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 36. Global Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 37. North America Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 38. North America Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 39. North America Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 40. North America Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 41. North America Systemic Mastocytosis Treatment Sales Share by Country (2016-2027)
    Figure 42. North America Systemic Mastocytosis Treatment Revenue Share by Country (2016-2027)
    Figure 43. U.S. Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 44. Canada Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 45. Europe Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 46. Europe Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 47. Europe Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 48. Europe Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 49. Europe Systemic Mastocytosis Treatment Sales Share by Country (2016-2027)
    Figure 50. Europe Systemic Mastocytosis Treatment Revenue Share by Country (2016-2027)
    Figure 51. Germany Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 52. France Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 53. U.K. Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 54. Italy Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 55. Russia Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 56. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 57. Asia Pacific Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 58. Asia Pacific Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 59. Asia Pacific Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 60. Asia Pacific Systemic Mastocytosis Treatment Sales Share by Region (2016-2027)
    Figure 61. Asia Pacific Systemic Mastocytosis Treatment Revenue Share by Region (2016-2027)
    Figure 62. China Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 63. Japan Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 64. South Korea Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 65. India Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 66. Australia Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 67. Taiwan Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 68. Indonesia Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 69. Thailand Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 70. Malaysia Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 71. Philippines Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 72. Latin America Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 73. Latin America Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 74. Latin America Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 75. Latin America Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 76. Latin America Systemic Mastocytosis Treatment Sales Share by Country (2016-2027)
    Figure 77. Latin America Systemic Mastocytosis Treatment Revenue Share by Country (2016-2027)
    Figure 78. Mexico Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 79. Brazil Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 80. Argentina Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 81. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Type (2016-2027)
    Figure 82. Middle East and Africa Systemic Mastocytosis Treatment Revenue Market Share by Type (2016-2027)
    Figure 83. Middle East and Africa Systemic Mastocytosis Treatment Sales Market Share by Application (2016-2027)
    Figure 84. Middle East and Africa Systemic Mastocytosis Treatment Revenue Market Share by Application (2016-2027)
    Figure 85. Middle East and Africa Systemic Mastocytosis Treatment Sales Share by Country (2016-2027)
    Figure 86. Middle East and Africa Systemic Mastocytosis Treatment Revenue Share by Country (2016-2027)
    Figure 87. Turkey Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 88. Saudi Arabia Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 89. U.A.E Systemic Mastocytosis Treatment Revenue (2016-2027) & (US$ Million)
    Figure 90. Systemic Mastocytosis Treatment Value Chain
    Figure 91. Systemic Mastocytosis Treatment Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed

Keyplayers in Global Systemic Mastocytosis Treatment Market Insights and Forecast to 2027

AB Science SA
AbbVie Inc
Arog Pharmaceuticals Inc
Blueprint Medicines Corp
Bristol-Myers Squibb Company
Deciphera Pharmaceuticals LLC
Novartis AG
Patara Pharma Inc
Seattle Genetics Inc
Stemline Therapeutics Inc